Pediatrics Onyx Clinical

Pediatrics and Neonatology

Pediatrics is a field of medicine related to the physical, mental and social health of children from birth to young adulthood. Pediatrics covers a wide range of medical services, from healthcare to the diagnosis and treatment of acute and chronic illnesses.

Pediatrics is a field related to the biological, social and environmental impacts on developing children and the developmental impacts of illness and dysfunction. Children are anatomically, physiologically, immunologically, psychologically, developmentally, and metabolically different from adults.

Pediatrician, a term that includes primary care pediatricians, pediatric  subspecialists, and pediatric surgery specialists, refers to this ever-changing functional state of patient growth and development and the consequent changes in the “normal” criteria of age. I understand. Pediatricians are doctors who are particularly qualified for these duties, with their primary concerns being the health, well-being and development of their children, and thanks to their interests and early training.


Information about Clinical Trials

Onyx Clinical’s Pediatric teams are experts in the scientific approach, standard of care, growing regulatory requirements, and operational factors required to bring medications and devices to market that treat or prevent issues with children. Our significant experience in dermatology studies, together with our proven track record of success in the Pediatric CRO market, means that we can adapt to each pediatric trial’s specific demands.

In order to ensure success, we help our clients:

  • Plan and conduct pediatric studies for drug/device and skin care safety in an efficient and effective manner.
  • Conduct big pediatric endpoint trials efficiently while adhering to stringent safety guidelines.
  • Integrate pediatrictrials without difficulty.


Cardiology and Vascular clinical trials
Pediatrics and Onyx Clinical

Crucial Pediatric Information

Deep and Broad Pediatric Experience

We’ve done hundreds of Phase I-IV  pediatric trials for pharmaceuticals and medical devices since our establishment in 2017.

We have learned the following from these studies: